MedCom USA, Inc. announced today that Source Capital Group, Inc. has initiated research coverage of the company with a “buy” rating and twelve- month price target of $5.10. The research was prepared by Joe E. Blankenship, Vice President Research for Source Capital, Inc.


MedCom USA, Inc. (EMED) provides innovative healthcare and financial transaction solutions for electronically processing HIPAA compliant transactions within the healthcare industry.


Next Article: Experian-Gallup Survey Shows 1 in 4 Consumers ...

Advertisement